OpenAlex
PricingAboutJobs
Log inGet started
Work

Extended-Release Physostigmine in Alzheimer Disease: A Multicenter, Double-blind, 12-Week Study With Dose Enrichment

HTML

Year: 2000
Type: article
Study design: Clinical Trial
Source: Archives of General Psychiatry
DOI: 10.1001/archpsyc.57.2.157
Authors: Christopher H. van Dyck, P Newhouse, W E Falk, J A Mattes
Institution: Yale University
Language: English

Topic: Cholinesterase and Neurodegenerative Diseases
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: physostigmine salicylate, Alzheimer's disease, acetylcholinesterase inhibitors, cognitive function, Clinical Global Impression of Change, gastrointestinal adverse effects, nausea and vomiting
SDG: Good health and well-being

Open Access status: closed

Funders: Massachusetts General Hospital, Ohio State University, Dartmouth College, National Institute of Neurological Disorders and Stroke
OpenAlex ID: W1567144778
FWCI: 1.702
Cites: 37
Cited by: 32
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security